Friday, February 19, 2010
100k Walk for Ian's Sore Eyes
It is with much gratitude to local Ultra Marathon Power Walker, Jacquie Farris and her Oak Bay High School Grad class of 1968 that we are excited to announce our 100K Walk for Ian's Sore Eyes in June 2010. To celebrate her 60th birthday, Jacquie will dedicate her 13-14hr 100k power walk to raise funds for Ian's medical costs while building public awareness about SJS.
Jacquie is herself an SJS survivor, living with significant permanent loss of the use of both hands and constant pain caused by complex regional pain syndrome & functional digit joint/tendon issues, which occurred as secondary complications to SJS which she initially experienced in 2002.
Ian's team is busy preparing the logistics of the event, so please check back for a confirmed date and further details as to how you can participate or contribute. For more information about SJS please visit www.milnesjs.com
Thursday, February 18, 2010
Accutane SJS warning by Health Canada
Health Canada has announced that Accutane, a popular medication used to treat acne, must now carry a warning stating the medication may cause rare, but potentially fatal skin reactions. The new warning stems from reports that some patients taking the medication have developed severe skin conditions such as toxic epidermal necrolysis and Stevens-Johnson syndrome.
A total of 66 serious skin reactions, two of which resulted in fatality, have been reported globally in patients taking the medication. According to Health Canada, the number of reported events presumably underestimates the number of Accutane patients that have experienced such reactions. While most of the reported occurrences involved factors other than Accutane, a correlation between the medication and the severe reactions has not been ruled out.
In the more than 25 years in which Accutane has been in circulation, the medication has been prescribed to approximately 16 million patients. During this time Accutane has been associated with other serious side effects such as the development of severe birth defects and miscarriage when taken by pregnant women. It has also been linked to an increase in depression and suicidal thoughts in some patients.
The maker of the drug, Hoffmann-La Roche, quietly pulled Accutane from the U.S. market and those of 11 other countries in 2009, citing growing competition from generics and a burdening string of law suits involving Accutane against the company.
Despite the new warning, Health Canada believes no additional action against Accutane is warranted and maintains the benefits of the medication still outweigh the risks.
For information about Stevens Johnson Syndrome visit www.milnesjs.com
Wednesday, February 17, 2010
SJS story on Mystery Diagnosis
To read Ian's story visit www.milnesjs.com
Friday, February 5, 2010
Thank you
For more information please visit www.milnesjs.com